Skip to main content

Table 1 The comparison of clinical characteristics among the three groups

From: A retrospective comparison of Sun’s tip-flexible semirigid ureterorenoscopy, super-mini percutaneous nephrolithotomy and flexible ureteroscopy applied to treat upper urinary tract calculi

Group

 

tf-URS group (n = 51)

SMP group (n = 46)

FURS group (n = 55)

F(x2) value

P value

Age

 

41.4 ± 14.6

41.4 ± 15.6

42.4 ± 13.2

F = 0.088

0.916

Body mass index (BMI)

 

24.25 ± 3.81

24.13 ± 4.07

24.66 ± 3.71

F = 0.276

0.759

Gender

    

x2 = 1.419

0.492

Male

 

25(49%)

28(61%)

29(53%)

  

Female

 

26(51%)

18(39%)

26(47%)

  

Stone location

    

x2 = 9.246

0.509

Renal calculi

Upper calyx

4(7.8%)

2(4.3%)

7(12.7%)

  

Middle calyx

10(19.6%)

6(13.0%)

5(9.1%)

  

Lower calyx

2(3.9%)

6(13.0%)

2(3.6%)

  

Renal pelvis

4(7.8%)

3(6.5%)

3(5.5%)

  

Upper ureteral calculi

 

24(47.1%)

24(52.2%)

30(54.5%)

  

Multiple locations*

 

7(13.7%)

5(10.9%)

8(14.5%)

  

Mean CT value (HU)

 

956 ± 231

1031 ± 270

991 ± 242

F = 1.144

0.321

Calculi diameter (cm)

 

1.3 ± 0.3

1.4 ± 0.3

1.4 ± 0.3

F = 0.667

0.515

Hydronephrosis#(cm)

 

1.7 ± 0.8

1.8 ± 1.1

1.9 ± 1.1

F = 0.440

0.645

The course of disease (d)

 

26.7 ± 15.3

26.9 ± 15.3

26.9 ± 13.8

F = 0.004

0.996

  1. *Multiple locations refers to the stones existing in two or more locations (upper calyx, middle calyx, lower calyx, renal pelvis or upper ureteral calculi)
  2. #Hydronephrosis refers to the dilatation of the renal pelvis and/or calyces
  3. The course of disease refers to the days calculated from the onset of symptoms or a positive imaging test without symptoms